Respiratory Flashcards
Stepwise long-term management of Asthma
(1) SABA
(2) SABA + ICS
(3) SABA + ICS + LTRA
(4) SABA + ICS + LABA
+/- Continue LTRA depending on their response to LTRA
(5) SABA + MART (w/ Low-dose ICS)
(6) SABA + MART (w/ Moderate-dose ICS)
(7) Specialist
- Muscarinic receptor antagonist
- Theophylline
- High dose ICS
- Oral prednisolone
Causes of upper lobe fibrosis
Tip: CHARTS
Coal workers pneumoconiosis
Hypersensitivity pneumonitis (= EAA)
Ank Spond + Aspergillosis (ABPA)
Radiation
TB
Sarcoidosis + Silicosis
Causes of lower lobe fibrosis
- Asbestosis
-
Connective tissue disorders (except Ank Spond –> Aprical)
- RA
- SLE
- Scleroderma
- Sjogren’s
- Polymyositis / Dermatomyositis
- Idiopathic pulmonary fibrosis
-
Drug-induced pulmonary fibrosis (BS NAME)
- Bleomycin, Busulfan
- Amiodarone
- Nitrofurantoin
- Sulfasalazine
- Methotrexate
Causes of drug related pulmonary fibrosis
Tip: BS NAME
- Bleomycin, Busulfan
- Amiodarone
- Nitrofurantoin
- Sulfasalazine
- Methotrexate
Causes of bilateral hilar lymphadenopathy
- TB
- Sarcoidosis
- Lymphoma
- Pneumoconiosis
- Fungi (Histoplasmosis, Coccidioidomycosis)
Classifying the different severities of Asthma
Define
- Inspiratory capacity
- Vital Capacity
- Total Lung Capacity
- Functional residual capacity
- Residual Volume
- Tidal Volume
- Inspiratory Reserve Volume
- Expiratory Reserve Volume
Borders of safe triangle
- Base of the Axilla
- Pectoralis major (lateral edge)
- 5th ICS
- Latissimus dorsi (anterior border)
Where to insert the chest drain
In safe triangle
ABOVE the rib
Obstructive pattern on spirometry is defined as
↓↓ FEV1 (<80% predicted)
↓ FVC (but decreases by a lesser extent)
FEV1:FVC < 70% (predicted) ==> Obstructive
Causes of obstructive lung disease
Asthma
COPD
Bronchiectasis
Bronchiolitis obliterans
Positive reversibility testing is defined as
↑ FEV1 which is > 200ml AND 12% of the pre-test value
Classification of severity of COPD
Name of classification?
Based on what factor?
GOLD Classification - based on FEV1
Mild COPD: FEV1 > 80% (predicted) - i.e. normalises after medication
Moderate COPD: FEV1 50-79% (predicted)
Severe COPD: FEV1 30-49% (predicted)
Very severe COPD: FEV1 < 30% (predicted)
Restrictive pattern on spirometry is defined as
↓ FEV1 (<80% predicted)
↓ FVC (<80% predicted)
FEV1:FVC ratio (>70%)
i.e. preserved ratio but absolute values for both FEV1 and FVC are both lower
Causes of restritive lung disease
- Pulmonary fibrosis
- Pneumoconiosis / Asbestosis
- Extrinsic allergic alveolitis
- Neuromuscular conditions
- Sarcoidosis
- Kyphoscoliosis / Ankylosing spondyltitis
- Neuromuscular conditions (affecting diaphragm)
Next investigation if
FEV1 < 80% predicted
reduced FVC
FEV1:FVC ratio < 0.7
Bronchodilator reversibility testing
Reversible –> Asthma (increase FEV1 by 200ml and 12%)
Irreversible –> COPD
TLCO is defined as
Total factor of the Lung for Carbon Monoxide
= rate at which a gas will diffuse from the alveoli into the blood
Carbon monoxide is used to test the rate of diffusion
Causes of increased and decreased TLCO
Varenicline
Indication?
MOA?
C/I
Varenicline
Indication: Smoking cessation
MOA: ACh receptor agonist –> reduced cravings of nicotine
C/I in Pregnancy, Breastfeeding
Caution: increased suicidal thoughts
Bupropion
Indication
MOA
C/I
Bupropion
Indication: Smoking cessation
MOA: NA and Dopamine re-uptake inhibitor (atypical antidepressant)
C/I in Pregnancy and Breastfeeding
S/E: Seizures
Pulsus paradoxus
Definition
Causes
Pulsus paradoxus = difference between sBP on inspiration and expiration > 20mmHg
Causes
- Severe asthma
- Cardiac tamponade
PERF variability
cut off?
indicates?
PEFR variability = (highest PEFR - lowest PEFR) / (average PEFR)
Uncontrolled asthma have ↑ variability in PEFR (worse in morning)
Values > 20% variability suggests asthma
Ix for diagnosis of (stable) Asthma
if High probability
if Intermidiate probability
High probability –> Trial treatment + Spirometry (FEV1 or serial PEFR)
Intermediate probability –> Spirometry + Bronchodilator reversibility
Obstructive pattern on spirometry
- ↓↓ FEV1 < 80% (predicted or best)
- ↓ FVC
- FEV1:FVC ratio < 70% (predicted or best)
+ve bronchodilator response
- ↑ FEV1 which is > 200ml AND 12% of the pre-test value
Ix to exclude Asthma if -ve Spirometry and -ve PEFR variability
Bronchial challenge test (using Histamine)
Negative test excludes Asthma
Asthma attack given nebulised salbutamol
ECG changes show?
Salbutamol
S/E: Hypokalaemia
ECG changse: TWI + U waves + long QU interval
Severe Asthma given IV MgSO4
S/E?
IV MgSO4
Hypotension
Severe asthma started on IV aminophylline
S/E?
Monitoring?
IV Aminophylline
cardiac arrhythmias
Requires cardiac monitor
Examples of asthma therapy
SABAs
LABAs
ICS
LTRA
SABAs
- Salbutamol
- Terbutaline
LABAs
- Salmeterol
- Formeterol
ICS
- Beclometasone dipropionate / Clenil
- Budesonide
LTRA
- Montelukast
Signs of well controlled asthma
Signs of well controlled asthma
- No daytime symptoms or waking at night
- No exacerbations
- No need for reliver inhaler
- Ideally, 1 SABA inhaler should last > 1 year
- No limitations on activity (including exercise)
- No asthma attacks
- Normal lung function (PEFR > 80% of predicted or best)
- Minimal S/E from medication
Kartagener’s syndrome triad
Kartagener’s syndrome
bronchiectasis
sinusitis
situs inversus
Causes of bronchiectasis
- Post-infection (Haemophilus influenzae - most common)
- Genetic
- Cystic fibrosis
- a1 antitrypsin
- Kartagener syndrome (ciliary dyskinetic syndrome)
- Yellow nail syndrome